HC-258 is a covalent acrylamide inhibitor of TEAD that reduces the CTGF, CYR61, AXL, and NF2 transcript levels and inhibits the migration of MDA-MB-231 breast cancer cells.
| Catalog Number | I047297 |
| Purity | ≥95% |
| Reference | [1] Fnaiche A, et al. ACS Med Chem Lett. 2023 Nov 30;14(12):1746-1753. |
